MedPath

Sambhav Program- an initiative to educate patientsabout Hepatitis C and help them manage the cost oftreatment.

Not Applicable
Conditions
Health Condition 1: null- Chronic HCV infection
Registration Number
CTRI/2015/09/006206
Lead Sponsor
MSD Pharmaceuticals Private Limited
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
600
Inclusion Criteria

Chronic HCV infection

Exclusion Criteria

NA

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Impact of Sambhav on treatment access and complianceTimepoint: 6 months duration for collection of data retrospectively
Secondary Outcome Measures
NameTimeMethod
oneTimepoint: None
© Copyright 2025. All Rights Reserved by MedPath